serap ata doktor / Dr. Burcu Işık Yeşilova (@dr.burcuisikyesilova) • Фото и видео в Instagram

Serap Ata Doktor

serap ata doktor

ID: covidwho-1522765


Реферат

BACKGROUND: Adherence to treatment is important in chronic dermatological diseases. There are limited data regarding the adherence to treatment in patients with psoriasis during the COVID-19 pandemic. AIMS: We aimed to determine the rates of adherence to systemic treatments in patients with psoriasis and to identify the causes of non-adherence during the COVID-19 pandemic. METHODS: We conducted a cross-sectional multicenter study from May 2021 to August 2021. A questionnaire including items regarding sociodemographic characteristics of the patients, disease-related characteristics, and treatment-related characteristics were filled out by the physicians. The Psoriasis Area Severity Index (PASI), Hospital Anxiety, and Depression Scale, and the Dermatology Life Quality Index were calculated. The rate of adherence and non-adherence to treatment and reasons for non-adherence to treatment were examined. RESULTS: A total of 342 patients with psoriasis were included (182 male/160 female) in the study. The mean age of the patients was 45.9 ± 14.2 years. The average duration of psoriasis was 192 ± 134.7 months. While the rate of adherence to treatment was 57.6%, the rate of non-adherence to treatment was 42.4%. There were no significant differences with respect to adherence to treatment in comparison with oral and injection-therapy groups. The most frequent reasons for non-adherence to treatment were inability to go to the hospital (19.2%), concern about the COVID-19 infection (16.3%), discontinuation of the treatment by the doctor (13.7%), inability to reach the doctor (7.3%), and inability to have access to the medication (7.3%). CONCLUSION: Adherence to oral and injection therapies was fairly high among our patients with psoriasis during the COVID-19 pandemic. Psoriasis severity and duration of medication use had a negative impact on adherence to treatment.


Тема - темы
COVID-19 , Psoriasis , Adult , Cross-Sectional Studies , Female , Humans , Male , Middle Aged , Pandemics , Psoriasis/drug therapy , Psoriasis/epidemiology , Quality of Life , SARS-CoV-2 , Severity of Illness Index

5.

Has the COVID-19 pandemic changed attitudes and behaviors concerning cosmetic care and procedures among patients presenting to the dermatology outpatient clinic? A multicenter study with 1437 participants.

Aslan Kayiran, Melek; Kara Polat, Asude; Alyamaç, Gökçen; Demirseren, Düriye Deniz; Tas, Betül; Kalkan, Göknur; Özkök Akbulut, Tugba; Kaya Özden, Hatice; Koska, Mahmut Can; Emre, Selma; Kaya Erdogan, Hilal; Tükenmez Demirci, Gülsen; Güngör, Sule; Özcan Arslan, Nimet; Agaoglu, Esra; Kurmus, Gökçe Isil; Aksoy, Hasan; Tatliparmak, Asli; Süslü, Hülya; Oguz Topal, Ilteris; Topaloglu Demir, Filiz; Acer, Ersoy; Duman, Hatice; Gürel, Mehmet Salih; Karadag, Ayse Serap.

J Cosmet Dermatol ; 20(10): 3121-3127, 2021 Oct.

Статья в английский править код]

ID: covidwho-233795


Реферат

Coronavirus disease (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) primarily affects the epithelium of the airways. With the increasing involvement of dermatologist in management of this crisis, cutaneous symptoms gained more and more attention. In this review, we will describe cutaneous symptoms of patients of all ages in association with COVID-19. We will focus on such disorders that are caused by direct action of SARS-CoV-2 on tissues, complement, and coagulation system and on nonspecific eruption of the systemic viral infection. Drug-induced reactions are only mentioned in the differential diagnoses. Although more systematic investigations are warranted, it becomes clear that some symptoms are clinical signs of a milder COVID-19 course, while others are a red flag for a more severe course. Knowledge of the cutaneous manifestations of COVID-19 may help in early diagnosis, triage of patients, and risk stratification.


Тема - темы
COVID-19/complications , SARS-CoV-2 , Skin Diseases/diagnosis , Alopecia/diagnosis , Chilblains/diagnosis , Exanthema/diagnosis , Humans , Lupus Erythematosus, Cutaneous/diagnosis
ID: covidwho-2192838


Реферат

PURPOSE: After the emergence of the pandemic caused by the COVID-19 virus, vaccination with various vaccines has started to be implemented across the world. To identify dermatological reactions developing after the COVID-19 vaccines administered in Turkey and determine their clinical features and risk factors that may play a role in their development. MATERIALS AND METHODS: The study included patients aged ≥18 years, who presented to 13 different dermatology clinics in Turkey between July 2021 and September 2021 after developing dermatological reactions following the administration of the COVID-19 vaccine. After providing written consent, the patients were asked to complete a standard survey including questions related to age, gender, occupation, comorbidities, the regular medication used, the onset of cutaneous reactions after vaccination, and localization of reactions. Dermatological reactions were categorized according to whether they developed after the first or second dose of the vaccine or whether they occurred after the inactivated or messenger RNA (mRNA) vaccine. The relationship between dermatological reactions and some variables such as gender and comorbidities was also evaluated. RESULTS: A total of 269 patients [116 women (43.1%), 153 men (56.9%)] were included in the study. It was observed that the dermatological diseases and reactions that most frequently developed after vaccination were urticaria (25.7%), herpes zoster (24.9%), maculopapular eruption (12.3%), and pityriasis rosea (4.5%). The rate of dermatological reactions was 60.6% after the administration of the mRNA vaccine and 39.4% after that of the inactivated vaccine. There was a statistically significantly higher number of reactions among the patients that received the mRNA vaccine (p = 0.001). CONCLUSION: The most common reactions in our sample were urticaria, herpes zoster, and maculopapular eruption. Physicians should know the dermatological side effects of COVID-19 vaccines and their clinical features.


Тема - темы
COVID-19 , Herpes Zoster , Male , Humans , Female , Adolescent , Adult , COVID-19 Vaccines/adverse effects , Turkey/epidemiology , COVID-19/epidemiology , COVID-19/prevention & control , Vaccination/adverse effects

4.

Adherence to systemic therapy in patients with psoriasis during the COVID-19 pandemic: A multicenter study.

Oguz Topal, Ilteris; Kara Polat, Asude; Zindanci, Ilkin; Kivanç Altunay, Ilknur; Akbulut, Tugba Özkök; Arikan, Eylem Emel; Topaloglu Demir, Filiz; Sivaz, Onur; Karadag, Ayse Serap.

J Cosmet Dermatol ; 21(1): 39-47, 2022 Jan.

Статья в английский

nest...

115538 115539 115540 115541 115542

batman iftar saati 2021 viranşehir kaç kilometre seferberlik ne demek namaz nasıl kılınır ve hangi dualar okunur özel jimer anlamlı bayram mesajı maxoak 50.000 mah powerbank cin tırnağı nedir